Awareness of HPV Vaccinations and Barriers to Vaccination Administration Among Underserved Women

Guerra, Rosa; Bhalwal, Asha; Ibarra, Claudia; Jooya, Neda; Robazetti, Sonia C.; Nugent, E.; Montealegre, Jane R.; Lucci, Joseph A.

doi:10.1016/j.ygyno.2017.07.111

Cited by 3 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While created de novo, the survey was influenced by previously published HPV awareness and attitude survey studies. 12,16,18,19 The final survey (Appendix A) contained the following: demographic information; HPV infection and vaccine awareness; HPV vaccination history; HPV infection and cervical cancer risk factors. Survey questions met a SMOG (Simple Measure of Gobbledygook) reading index of 7th grade and a Gunning Fog score of 8.6, designating it "fairly easy to read."…”

Section: Methodsmentioning

confidence: 99%

Human Papillomavirus Awareness, Vaccine Status, and Risk Factors in Female Emergency Patients

Walter

Leader

Galbraith

2020

WestJEM

View full text Add to dashboard Cite

Introduction: A vaccine targeting high-risk human papillomavirus (HPV) strains can effectively prevent HPV-associated cervical cancer risk. However, many girls and women do not receive the vaccine, more often those impacted by health disparities associated with race and/or socioeconomic status. This same disparate population has also been shown to be at higher risk for cervical cancer. Many of these women also rely on the emergency department (ED) as a safety net for their healthcare. This study sought to gather information pertaining to HPV and cervical cancer risk factors, awareness of HPV and the vaccine, as well as HPV vaccine uptake in female patients presenting to an ED. Methods: We obtained 81 surveys completed by female ED patients. Demographics included age, race, income, insurance status, primary care provider status, and known cervical-cancer risk factors. Subsequent survey questions explored respondents’ knowledge, familiarity, and attitudes regarding HPV, cervical cancer, and the HPV vaccine, including vaccination uptake rates. We analyzed data using descriptive statistics and Fisher’s exact test. Results: Approximately one in seven respondents (14.8%) had never previously heard of HPV and 32.1% were unaware of the existence of a HPV vaccine. Minority patients, including those who were Black and Hispanic patients, low income patients, and uninsured and publicly insured patients were less likely to be aware of HPV and the vaccine and likewise were less likely to be offered and receive the vaccine. More than 60% of all respondents (61.3%) had never previously been offered the vaccine, and only 24.7% of all respondents had completed the vaccine series. Conclusion: Female ED patients may represent an at-risk cohort with relatively low HPV awareness and low HPV vaccine uptake. The ED could represent a novel opportunity to access and engage high-risk HPV populations.

show abstract

Section: Methodsmentioning

confidence: 99%

Human Papillomavirus Awareness, Vaccine Status, and Risk Factors in Female Emergency Patients

Walter

Leader

Galbraith

2020

WestJEM

View full text Add to dashboard Cite

show abstract

“…While this project did not analyze results by race or gender, there are large Hispanic and African American populations at Smyrna Pediatrics. Data from Guerra et al suggested that both "Hispanic and African American women have the highest incidence of cervical cancer…[and] increasing HPV vaccination rates will help reduce [this] burden" [14]. Evidence demonstrates that the immunization rate can be increased by an improvement in education and communication, which was the basis for this scholarly project [14].…”

Section: Relationship Of Results To Framework/aims/objectivesmentioning

confidence: 98%

“…Data from Guerra et al suggested that both "Hispanic and African American women have the highest incidence of cervical cancer…[and] increasing HPV vaccination rates will help reduce [this] burden" [14]. Evidence demonstrates that the immunization rate can be increased by an improvement in education and communication, which was the basis for this scholarly project [14]. In Kulczycki et al, there were three main communication barriers for the administration of the vaccine, which included "patients' and parents' unwillingness/reluctance to discuss HPV...their limited awareness of it, and inadequate access/ use of healthcare" [15].…”

Section: Relationship Of Results To Framework/aims/objectivesmentioning

confidence: 99%

“…Articles that addressed pediatric and adult populations were both included as to have the most substantial amount of data present. Three articles were selected that discussed effective patient and provider education, addressed concerns of patients and their parents or guardians, and utilized innovative education and communication about the 9vHPV vaccine [14][15][16].…”

Section: Synthesis Of Evidence Literature Searchmentioning

confidence: 99%

See 1 more Smart Citation

A Quality Improvement Project to Increase the Rate of HPV Vaccination Initiation in Adolescents

2018

JCEI

View full text Add to dashboard Cite

The vaccination rate of the human papilloma virus vaccine [9vHPV] is low, with only 63% of eligible females and 50% eligible males receiving the vaccine in 2016. The aim of this quality improvement project was to increase the initiation rate of HPV vaccination at Smyrna Pediatrics by 20%, from 3.6% to 4.3% over four weeks. Two physicians, one nurse practitioner, and two medical assistants implemented this quality improvement initiative. There is a lack of education and standardized communication about HPV and 9vHPV to prevent against the virus. A standardized script was created so that all conversations between healthcare professionals and patients and their parents or guardians included the wording of the 9vHPV being recommended rather than optional. Educational material from the CDC was the standard handout given to each adolescent and their parent or guardian. Standardized education and communication was to be provided at each adolescent visit of the 125 eligible adolescents seen during the four-week implementation period, 4% (n = 5) agreed to receive the 9vHPV vaccine. With a baseline of 3.6% (n = 4), there was an 11.1% increase of initiation of 9vHPV. The use of standardized education documents presented to all patients and their parents or guardians established health education as the mainstay of the project and provided information about the importance of prevention and protection from the virus that the vaccine prevents. The implementation of results over a longer period of time may prove to be more effective for the practice’s increase of vaccination rates overall.

show abstract

Cervical Human Papillomavirus Testing With Two Home Self-Collection Methods Compared With a Standard Clinically Collected Sampling Method

et al. 2019

View full text Add to dashboard Cite

Background The purpose of this study was to compare the outcomes of 2 self-collection methods to detect cervical human papillomavirus (HPV) DNA with outcomes from a standard clinical method. The standard method samples were collected by a clinician at a routine pelvic examination. Self-samples were taken at home and mailed to the clinical laboratory. Methods The 2 self-collection methods were a tampon-based method and a swab-based method using a commercial device, an Eve Medical HerSwab. All HPV samples were processed by a clinical laboratory using the Food and Drugs Administration approved Roche Cobase HPV method, which specifically identifies HPV 16, HPV 18, and a set of 12 other high-risk subtypes. Patients were recruited from 2 cancer screening clinics 2015 to 2017. All patients signed an informed consent. Screening outcomes, such as prevalence, percent agreement with standard, sensitivity, and specificity, were calculated for each self-collection method. Measures of similarity between self and standard collection outcomes, Cohen’s κ, percent concordance, McNemar equivalence, and others were tested statistically. Results One hundred seventy-four patients were randomized. The prevalence of 1 or more positive HPV high-risk subtypes from the standard clinical specimens was 13.5%. All clinical specimens were sufficient for valid HPV detection. For the tampon method, 15 (27%) of the specimens were insufficient quality. Only 1 (2%) swab specimen was insufficient. Only the swab self-collection method was found to be statistically noninferior to the clinical method. The tampon method had an unacceptably high rate of insufficient quality specimens and also failed the equivalency tests. Conclusions The swab home collection samples were equivalent to the clinical samples, but the tampon method had an unacceptably high rate of specimens insufficient for HPV detection.

show abstract

Awareness of HPV Vaccinations and Barriers to Vaccination Administration Among Underserved Women

Cited by 3 publications

References 0 publications

Human Papillomavirus Awareness, Vaccine Status, and Risk Factors in Female Emergency Patients

Human Papillomavirus Awareness, Vaccine Status, and Risk Factors in Female Emergency Patients

A Quality Improvement Project to Increase the Rate of HPV Vaccination Initiation in Adolescents

Cervical Human Papillomavirus Testing With Two Home Self-Collection Methods Compared With a Standard Clinically Collected Sampling Method

Contact Info

Product

Resources

About